Search Results 501-510 of 18297 for Lactation

1. Publications - Cesar A. Gonzalez, Ph.D., L.P., ABPP - Mayo Clinic

   2022; 29. Oberhelman-Eaton S, Chang A, Gonzalez C, Braith A, Singh RJ, Lteif A. Initiation of Gender-Affirming Testosterone Therapy in a Lactating Transgender ...

2. A Study to Compare Venetoclax with Fulvestrant vs. Fulvestrant Alone in Women with Locally Advanced or Metastatic HER2-negative Cancer who Have Progressed or Recurred on a CDK4/6 Inhibitor - Mayo Clinic

   Pregnant, lactating, or intending to become pregnant during the study. Known untreated or active CNS metastases (progressing or requiring anticonvulsants or ...

3. Long-term Safety With Vedolizumab Intravenous (IV) in Pediatric Participants With Ulcerative Colitis (UC) or Crohn's Disease (CD) - Mayo Clinic

   Is female and is lactating or pregnant. Has hypersensitivity or allergies to vedolizumab or any of its excipients. Has withdrawn from Study MLN0002-2003 ...

4. Nivolumab and Brentuximab Vedotin After Stem Cell Transplant in Treating Patients With Relapsed or Refractory High-Risk Classical Hodgkin Lymphoma - Mayo Clinic

   Women who are pregnant or lactating. History of a cerebral vascular event (stroke or transient ischemic attack), unstable angina, myocardial infarction, or ...

5. Ph 1b Study to Evaluate GSK2110183 in Combination with Bortezomib and Dexamethasone in Subjects with Multiple Myeloma - Mayo Clinic

   Pregnant or lactating female. History of known HIV infection. Subjects with a positive test for Hepatitis C (HCV) antibody are excluded, regardless of viral ...

6. A Study of LOXO-292 in Patients with Advanced Solid Tumors, RET Fusion-Positive Solid Tumors, and Medullary Thyroid Cancer - Mayo Clinic

   Pregnancy or lactation. Active second malignancy other than minor treatment of indolent cancers. History of hypersensitivity to any of the study drug ...

7. Taletrectinib Phase 2 Global Study in ROS1 Positive NSCLC - Mayo Clinic

   Pregnancy or lactation/breastfeeding. 13. Use of food or drugs that are known potent cytochrome P450 3A4/5 (CYP3A4/5) inhibitors or inducers or P ...

8. Phase 1/2 Study of AG-221 in Subjects With Advanced Hematologic Malignancies With an IDH2 Mutation - Mayo Clinic

   Subjects who are pregnant or lactating. Subjects with an active severe infection that required anti-infective therapy or with an unexplained fever >38.5°C ...

9. Molecular Regulation of Muscle Glucose Metabolism - Mayo Clinic

   Subjects may be of either sex, age as described in each protocol. Female subjects must be non-lactating and must either be at least two years post ...

10. A Study to Evaluate a New Anti-Cancer Vaccine for Patients with Non-Small Cell Lung Cancer, Given After Tumor Removal by Surgery - Mayo Clinic

    Pregnant or lactating. Participating Mayo Clinic locations. Study statuses change often. Please contact the study team for the most up-to-date information ...